As shown in Figure 1b, the top five genes, including GPR156, RIMS2, GDPD4, SAMD9, and DPF1, showed significantly higher expression in primary tumors of ESCC patients with metastatic recurrence compared to that without recurrence. This evidence concerns the gene RIMS2 and esophageal squamous cell carcinoma.